In July there was over $6.5 billion raised by companies in the biotech and biopharma space. Within this blog, we delve into our key findings, and the companies raising these funds. You can subscribe to monthly biotech funding updates over on Katie Davis’ LinkedIn to keep up to date with the ever-growing biotech market.

 


 

The largest amount of money raised was by AstraZenica who raised over $1.5 billion in Post-IPO Debt.

The largest amount raised by a private company was by Element Biosciences who raised $277 million in their series D funding round.

Over $2.5 billion was raised between Pre-Seed and Series D funding rounds. The table below shows the full breakdown.

 

July funding rounds - funding type table

 

25,000 100XBIO (MA, USA) develops an automated platform for multiplex T-cell analysis to disrupt the market dominated by laborious and manual procedures. The latest investment brings the total raised by 100XBIO to $200K.

44,666 TrueYouOmics (Switzerland) offers the most comprehensive blood test, via multi-omics and AI, for disease risk identification and prevention planning.

1,082,532 Meddenovo Drug Design (France) offers leading AI-driven drug design, specializing in high-tech molecular modelling with a focus on cyclic peptide therapeutics.

1,200,000 Briefly Bio (United Kingdom) is a biotech platform that provides a solution to make lab work reproducible.

2,200,000 Gelomics (Australia) offers photocrosslinkable extracellular matrix kits with tunable mechanical properties for 3D cell and organoid culture, tissue engineering and bioprinting.

250,000 pre-seed & $1.75 million additional funds from SOSV and the Partnership Fund Cell BioEngines (NY, USA) provide allogeneic ‘Off-the-Shelf’ cell-based therapies and services.

Unknown Synamics Therapeutics (Denmark) works towards adaptive medicine, focusing on designing adaptable drugs that can counteract cancer’s evolving resistance mechanisms. Leveraging AI and advanced computational techniques, the startup provides precision medicine.

 

seed funding logos

 

100,000 Gnosko Bio (PA, USA) provides the only real-time inventory automation solution in the life science industry.

200,000 Phycin (MD, USA) is an algae-based platform that manufactures growth factors for eye care, cell culture, and clean meat production.

1,375,894 MingCeler (China) is a Bio-Island Laboratory incubation enterprise focused on developing TurboMiceTM tetraploid compensation technology.

1,825,445 Alixia (CA, USA) is a medical research company that engages in developing new modalities to treat cancer, aging, and inflammation.

2,000,000 Sunflower Therapeutics (MA, USA) is a biotech company that delivers next-generation protein manufacturing solutions.

2,000,000 ImmuneAGE Bio is a drug discovery platform focused on rejuvenating the immune system.

3,500,000 Modicus Prime (IN, USA) has AI software that automates biologics image analysis to accelerate process development and reduce commercial production costs.

4,000,000 Biostate AI (CA, USA) mission is to develop generative AI that can benefit all of human health. We observe that biological beings are dynamic systems, with each individual slightly different today vs. yesterday or tomorrow.

4,500,000 Endless Health (TX, USA) provide easy, in-home testing for the best biomarkers to predict long-term cardiovascular and metabolic health, AI or live human coaching, and easy progress tracking of the lifestyles that prevent 80% of cardiovascular disease; then we re-test health markers to cement the lifestyle changes that do improve health markers, hence full-loop health support.

4,608,685 Pan Cancer (The Netherlands) exploits 20 years of pioneering research in the field of adoptive T-cell therapies.

5,200,000 Predicta Biosciences (MA, USA) uses multi-omics and liquid biopsies in precision oncology to create innovative diagnostics and therapies.

6,736,333 Spotlight Medical (France) develops AI tests to revolutionize cancer treatment, providing everyone with the best possible chance to beat cancer.

7,140,000 Granza Bio (CA, USA) is a company that developing cancer therapies based on human body’s immune system.

8,000,000 Montara Therapeutics (CA, USA) is developing safer, more efficacious therapies to improve the lives of patients with neurological diseases.

10,744,047 Kvantify (Denmark) provides Quantum computing and HPC software solutions that address hard computational challenges.

13,128,600 Draupnir Bio (Denmark) is developing a new type of cholesterol-lowering medicine which prevents blood clots in the heart.

14,000,000 Xellar Biosystems (MA, USA) is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.

Unknown Alkira Bio (Australia) enables the discovery of next-generation therapeutic antibodies that target complex membrane proteins.

 

series a funding logos

 

7,198,511 Overseed (France) is an biotechnology based company which does R&D process on cannabis production for pharmaceutical purposes.

7,300,000 AnBogen Therapeutics (Taiwan) is a clinical-stage biotech company to creating breakthrough science that changes the life of cancer patients.

8,724,738 Integra Therapeutics (Spain) is a developer of next generation of gene editing tools to cure diseases.

9,000,000 Myrobalan Therapeutics (MA, USA) is a biotech firm that develops oral neurorestorative therapies to reverse key brain dysfunctions and CNS conditions.

11,978,126 Immuneel Therapeutics Bengaluru, Karnataka, India. Immuneel Therapeutics is a biotechnology startup that focuses on cell therapy and personalized immunotherapy for patients.

12,500,000 Kanvas Biosciences (NJ, USA) is mapping interactions foundational to therapeutic discovery and human health.

13,758,943 Antiy Sunshine (China) develops antisense oligonucleotide (ASO) drugs targeting RNA splicing and RNA editing.

13,769,932 Shandong Bona Group (China) is a biotechnology company that specializes in the development of material separation, extraction and purification.

13,792,342 Bivision (China) is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT).

Over 14,000,000 UniXell Biotechnology (China) is a new-generation cell therapy drug developer, focuses on the development of a new generation of cell therapy drugs.

15,000,000 Oisin Biotechnologies (WA, USA) is a drug development company focused on mitigating the senolytic technology to combat age-related diseases.

16,497,113 Kangfude Pharmaceutical (China) is a pharmaceutical company that specializes in the development and manufacturing of cytotoxic anti-tumor APIs.

17,000,000 PineTree Therapeutics (MA, USA) engages in the development of disruptive therapies in Oncology and Immuno-oncology.

20,000,000 LTZ Therapeutics (CA, USA) develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.

30,000,000 ReviR Therapeutics (CA, USA) is a genomics-based platform that develops novel medicines targeting human RNAs.

35,000,000 Rona Therapeutics (China) is a RNA therapeutics platform enabling discovery, development of modular and programmable RNA medicines.

37,000,000 AusperBio (China) is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.

45,000,000 Spear Bio (MA, USA) is a biotech company that focuses on the detection of ultrasensitive protein.

60,000,000 AIRNA (MA, USA) is a biotech company that is pioneering RNA editing therapies to improve the health of individuals.

65,000,000 Brenig Therapeutics (DE, USA) develops therapies for neurodegenerative disorders.

68,190,674 SciRhom (Germany) is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.

114,000,000 Myricx Bio (United Kingdom) is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer.

122,000,000 NGM Biopharmaceuticals (CA, USA) is a biopharmaceutical company focused on discovering and developing novel, life-changing medicines for people whose health and lives have been disrupted by disease.

165,000,000 Third Arc Bio (MA, USA) is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.

Unknown Shengbao Bio (China) is committed to the development of novel live bacterial medications, leveraging gene circuits and precise regulation of gene.

 

series b funding

 

22,500,000 NOWDiagnostics (AR, USA) develops and manufactures diagnostic tests that utilize a single drop of blood and deliver results within minutes.

33,000,000 Foresight Diagnostics (CO, USA) develops novel technology for detect cancers from a simple blood draw.

60,000,000 GRO Biosciences (MA, USA) is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.

65,148,419 Confo Therapeutics (Belgium) is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.

80,000,000 CytoReason (Israel) develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.

260,000,000 Cardurion Pharmaceuticals (MA, USA) is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.

Unknown Ancient Times of Genomics (China) is an innovative company that provides solutions for clinical precision treatment of respiratory specialists.

 

series c funding logos

 

16,228,567 HepaRegeniX (Germany) is developing drugs for treating acute and chronic liver diseases.

27,500,000 Baoji Pharmaceutical (China) is a biopharma R&D manufacturer, a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production.

41,276,830 MoonBiotech (China) is a biotechnology company focused on the commercialization of microbial resources.

100,000,000 Autobahn Therapeutics (CA, USA) is a developer of regenerative medicines to restore hope for people affected by CNS disorders.

100,000,000 Asceneuron (Switzerland) develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.

150,000,000 Scorpion Therapeutics (MA, USA) is a clinical-stage oncology company that specializes in precision medicine for cancer patients.

 

series d funding logos

 

28,172,940 TMRW Life Sciences (NY, USA) provides an integrated platform for automated, software-guided cryospecimen management.

42,000,000 Scopio Labs (Israel) provides digital cell morphology imaging and AI solutions for hematology microscopy and diagnostics.

54,000,000 Circle Pharma (CA,USA) is a provider of a macrocycle development platform intended to provide macrocyclic peptides.

150,000,000 CatalYm (Germany) is a biotechnology company developing innovative immunotherapies for cancer patients.

277,000,000 Element Biosciences (CA, USA) is a life science company that focuses on developing innovative genetic analysis tools.

 

grant funding logos

 

170,735 Amporin Pharmaceuticals (Switzerland) seeks to create a new class of small-molecule medications.

192,200 Forward BIOLABS (WI, USA) is a biotechnology research company that provides lab equipment and infrastructure, lab services, and office amenities.

366,715 HDAX Therapeutics (Canada) are Pioneering next-gen precision therapeutics for diseases stemming from microtubule dysfunction, such as neuropathies and cardiovascular diseases.

366,715 Tenomix (Canada) has a mission is to develop novel technologies that target inefficiencies in the pathology workflow and optimize cancer care.

366,715 Novel Biotechnology (Canada) operates as a biotechnology company and develops innovative solutions for plasmid DNA production.

403,271 Medannex (United Kingdom) is an award-winning Scottish biopharmaceutical company committed to unlocking the therapeutic potential of targeting annexin-A1.

812,741 ThirtyFiveBio (United Kingdom) is an early-stage drug discovery company that was established in 2021 by a team of experienced pharmaceutical industry professionals and biotech entrepreneurs.

900,000 Anebulo Pharmaceuticals (TX, USA) is a biotech company developing novel solutions for people suffering from cannabinoid overdose and substance addiction.

1,100,000 Apriori Bio (MA, USA) offers a platform for creating variant-resilient vaccines and provides real-time insights to prepare for future outbreaks.

2,032,485 Recce Ltd. (Australia) is a world leader in synthetic polymer-antibiotics.

2,100,000 Resolute Science (CA, USA) is creating a new class of medicines for aggressive solid tumors that are uncommon and challenging to treat.

$2.785m grant and $7.8m equity investment Apmonia Therapeutics (France) is a biotech company that develops therapeutic strategies for cancer.

2,781,000 JAXBIO Technologies aims to change the way cancer is diagnosed and managed, with a simple and sensitive blood test.

2,880,000 ReCerise Therapeutics (South Korea) is a bio-venture company that researches and develops targeted therapies for treatments of liver disease area.

2,900,000 RenBio (NY, USA) develops antibody-based therapeutic solutions for the treatment of cancer and inflammatory diseases.

3,000,000 Orlance (Spain) provides more effective therapeutic and preventive vaccines for a wide spectrum of viral targets.

3,600,000 Salk Institute for Biological Studies (CA, USA) conducts research on molecular biology and genetics, neurosciences, and plant biology.

4,000,000 Herantis Pharma (Finland) is a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s disease.

4,000,000 Rejuvenate Bio (CA, USA) is a biotechnology company that develops therapies to reverse aging and treat age-related diseases.

4,500,000 Leuko (MA, USA) develops non-invasive white blood cell monitoring device.

5,200,000 MISSION Therapeutics (United Kingdom) develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.

5,250,000 Armata Pharmaceuticals (CA, USA) is a biotechnology company developing novel products to diagnose, treat and prevent human and animal diseases.

6,073,293 Lario Therapeutics (United Kingdom) is a biopharmaceutical firm that develops precision therapeutics for epilepsy and neurological disorders.

8,000,000 Nexcella Utilize cell therapies to create safe and effective medicines for oncology and other conditions, improving patient outcomes.

8,000,000 Senti Biosciences (CA, USA) is a biotechnology company that focuses on synthetic biology and gene circuit engineering for therapeutic applications.

8,540,988 Immuno Cure (Hong Kong) is a biotechnology company it is specialized in the study and creation of immunotherapies.

10,000,000 Schrodinger (NY, USA) is a healthcare-based software company that develops molecular design software for biotech and materials research.

11,000,000 Antheia (CA, USA) is a synthetic biology company for next generation plant-inspired medicines.

16,501,045 STEMCELL Technologies (Canada) offers scientists a range of products and tools to isolate, culture, and assay cells.

27,000,000 Wyss Institute (MA, USA) is a research institute developing biologically inspired materials and devices to solve critical medical and environmental problems.

31,000,000 Weill Cornell Medicine (NY, USA) is an academic medical institution that offers health care services.

34,000,000 CastleVax (USA) operates as a clinical-stage vaccine research company.

41,300,000 Valneva (France) focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

44,000,000 Advanced Regenerative Manufacturing Institute (NH, USA) is a member-based nonprofit organization.

53,418,215 Aspect Biosystems (Canada) is a biotech company developing bioprinted tissue therapeutics to transform how we treat disease.

176,000,000 Moderna (MA, USA) is a biotechnology company that specializes in vaccines and drug development.

Unknown RICOVR Healthcare (NJ, USA) is a medical device company with ultra-sensitive rapid diagnostics platform for THC and COVID19.

Unknown American Liver Foundation (NY, USA)  facilitate, advocate and promote education, support and research for the prevention, treatment and cure of liver disease.

Unknown National Kidney Foundation (NY, USA) is a major voluntary health organization in the United States.

 

private equity logos

 

5,000,000 Noze (Canada) enables early disease detection through an AI-powered sense of smell.

54,160,971 SmartCella (Sweden) is a biotechnology company developing cell therapy and delivery devices for cardiac diseases.

Unknown Maxim Biotech (MD, USA) provides vitro diagnostic testing development and testing solutions.

 

corporate round logos

 

4,000,000 invIOs (Austria) is a private biotech company that specializes in the discovery and development of next-generation cancer therapies.

25,000,000 Dren Bio (CA, USA) focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.

Unknown IASO Biotherapeutics (China) is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.

Unknown Sequrna (Sweden) make RNA-sequencing workflows affordable, collaborative, and sustainable.

 

convertible note

 

14,000,000 MiNDERA Corporation (CA, USA) conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases.

 

post-ipo equity logos

 

100,000 Psycheceutical (FL, USA) is a patented delivery technology that provides safe bioavailable psychedelic pharmaceutical medicines.

299,460 Algernon Pharmaceuticals Delta (Canada) company is focused on developing, in-licensing, and commercializing proprietary innovative.

433,304 Arch Biopartners (Canada) is a late stage clinical trial company focused on the development of novel therapeutics targeting organ inflammation.

1,110,000 Onconetix (OH, USA) is a biotechnology company that focuses on research and development of universal flu vaccines.

1,935,000 Aspira Women’s Health (TX, USA) develops and commercializes diagnostic tests that address unmet needs in gynecologic oncology and women’s health.

2,000,000 Purple Biotech (Israel) is an innovative biopharmaceutical drug development company.

2,031,980 Regeneron (NY, USA) specializes in the discovery, development, and commercialization of innovative medicines.

2,100,000 Silo Pharma (NJ, USA is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research.

3,000,000 Transcode Therapeutics (MA, USA) is an emerging RNA oncology company committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics.

3,100,000 Phio Pharmaceuticals (MA, USA) is a biotechnology company specializing in the application of RNAi therapies in immuno-oncology.

4,871,395 Aelis Farma (France) Aelis Farma is a biotech company conducting research and development on innovative signaling specific drugs.

5,000,000 Biodexa Pharmaceuticals (United Kingdom) is a pharmaceutical company focused on particle engineering with an emphasis on microfluidics and drug delivery.

9,000,000 Longeveron (FL, USA) is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.

10,000,000 Imunon (NJ, USA) is developing new medicines that harness the building blocks of life to work in harmony with the body’s immune system.

10,000,000 Chemomab (Israel) is a clinical-stage biotech company focusing on the discovery and development of innovative therapeutics.

10,000,000 Rani Therapeutics (CA, USA) is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

10,845,000 CEL-SCI (VA, USA) is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

12,000,000 Checkpoint Therapeutics(MA, USA) is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.

12,900,000 Windtree Therapeutics (PA, USA) is a clinical-stage focused on developing novel surfactant therapies for respiratory diseases and other potential applications.

13,750,000 MediWound (Israel) is a biotechnology specialty company focused on developing, manufacturing and commercializing innovative wound care products.

15,400,000 Teknova (CA, USA) is a biotechnology company that offers DNA sequencing, clone testing and clone-based crop research services.

18,058,886 Psyence Biomedical (Canada) is a life science biotechnology company that focuses on advancement of psychedelic medicines.

21,000,000 SELLAS Life Sciences (Bermuda) is a late-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications.

30,000,000 LENZ Therapeutics (CA, USA) operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.

30,000,000 Bionano Genomics (CA, USA) is a biotechnology company that provides genome analysis solutions to researchers and clinicians.

31,062,354 AROBS (Romania) is an IT solution provider of ready-to-use systems and tailor-made software based on the latest technologies.

35,000,000 Ocugen (PA, USA) is a biotechnology company that develops novel gene and cell therapies to improve health and patient outcomes.

55,000,000 Verastem Oncology (MA, USA) is a biopharmaceutical company that focuses on discovering and developing novel drugs that selectively target cancer stem cells.

122,700,000 ProMIS Neurosciences (Canada) develops therapeutic products and diagnostic devices targeting misfolded protein diseases.

130,000,000 Cartesian Therapeutics (MD, USA) In November 2023, Selecta Biosciences Inc. merged with Cartesian Therapeutics to create a publicly traded company pioneering RNA cell therapy to treat autoimmune disease.

175,000,000 Day One Biopharmaceuticals (CA, USA) develops targeted therapies to treat people with life-threatening diseases.

263,000,000 IDEAYA Biosciences (CA, USA) is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.

Unknown Indivior (VA, USA) is a global pharmaceutical company working to help change patients’ lives by developing medicines to treat substance use disorder and serious mental illnesses.

 

post-ipo secondary logos

 

1,111,135 Vertex Pharmaceuticals (MA, USA) is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.

 

post-ipo debt logos

 

1,460,576 IPA (ImmunoPrecise Antibodies) (Canada) is a full-service, bioplatform-based and AI-driven company, specialized in next-gen antibody discovery for therapeutics.

2,000,000 Trevena (PA, USA) is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.

2,500,000 Virpax Pharmaceuticals Inc. (PA, USA) is committed to developing non-addictive product candidates that manage severe pain.

15,000,000 Cytosorbents (NJ, USA) develops therapeutic devices used in purifying blood to treat life-threatening diseases.

250,000,000 OPKO Health (FL, USA) engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.

431,372,601 Telix Pharmaceuticals (Australia) a clinical-stage biotechnology company focused on the development of diagnostic and therapeutic products.

1,515,556,648 AstraZeneca (United Kingdom) is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.

Unknown Hepion Pharmaceuticals (NJ, USA) provides the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and chronic hepatitis virus infection (HBV, HCV, HDV).

 

debt financing logos

 

200,000 General Prognostics (GPx) (MA, USA) is a digital therapeutics company that revolutionizes remote chronic disease management with bloodless blood tests.

15,000,000 Velentium (TX, USA) is a manufacturer of therapeutic and diagnostic medical devices.

 

funding round logos

 

1,000,000 Dynamic Cell Therapies (MA, USA) develops controllable CAR T cells for the treatment of cancers.

2,270,086 Argonaute RNA (United Kingdom) company research projects build on existing intellectual property.

7,500,000 Legacy (NY, USA) is a digital fertility clinic for men, founded at Harvard & backed by Y Combinator, FirstMark Capital, Bain Capital and celebrities.

13,500,000 ImPact Biotech (Israel) is a biotechnology company that develops Padeliporfin VTP therapy to treat solid tumors.

13,761,405 Singlera (China) is a medical firm that is working to overcome the delay in early diagnosis of cancer through screening and auxiliary.

14,999,999 Primrose Bio (CA, USA) is a biotechnology company that focuses on discovery, development, and manufacturing of new molecules.

35,000,000 CellCentric (United Kingdom) is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy.

36,666,333 eTherapeutics (United Kingdom) focuses on the discovery of cancer and degenerative diseases of the nervous system.

74,000,000 Truvian Sciences (CA, USA) develops an automated benchtop system to provide lab-accurate blood testing results.

 

*All findings throughout this blog article were founded from Crunchbase (2024). Crunchbase is the leading destination for company insights from early-stage startups to the Fortune 1000.)

 


 

If you’re a biotech startup looking for talent, or you’d like to learn more about our recruitment services, submit your vacancy and a recruitment consultant that specialises in your biotech field will be in touch shortly.

Alternatively, are you seeking advice on your next move? I’m here to help. Register with us today to schedule a confidential discussion about your career prospects.